COLD-FX is Proudly Canadian

• It was invented and developed in Canada in partnership with seven Canadian universities
• It consists of North American ginseng – 100% of which is grown in North America; 90% from Canada and 10% from the United States
  
• The company is Canadian
  
• All but one early step in COLD-FX’s extensive manufacturing process take place in Canada and all employ Canadian technology and expertise. This early step takes place in China.

China has a historical and deep expertise in processing ginseng, handling 97 percent of the world supply, and it is for this reason that the extraction process occurs outside of Canada. After this step the material is returned to Canada for the remainder of the manufacturing process, including Quality Assurance testing against Health Canada-established criteria, and every stage of the process meets or exceeds all applicable Canadian manufacturing regulatory requirements. A total of 42 quality tests are conducted on each batch of COLD-FX.

Clinical trials establishing COLD-FX’s safety, efficacy, and mechanism of action have been conducted at seven Canadian universities, and published in peer reviewed publications including the country’s foremost scientific journal, the Canadian Medical Association Journal.

Afexa Life Sciences is proud of COLD-FX's Canadian heritage and its role in helping to reduce the frequency, severity and duration of colds and flu by boosting the immune system.